Rep. Grimm Urges FDA to Rule against Allowing Generic OxyContin to Hit the Market Tuesday without Abuse-Deterrent Properties

WASHINGTON, DC – April 15, 2013 – (RealEstateRama) — Rep. Michael G. Grimm (R,C-NY) issued the following statement on the upcoming FDA ruling on allowing generic opioids, such as OxyContin and Opan, to hit the market this Tuesday